ArticleRadiology2019
Association between Nonalcoholic Fatty Liver Disease at CT and Coronary Microvascular Dysfunction at Myocardial Perfusion PET/CT.
Open access · greenAbstract read
In one paragraph
Article in Radiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.
0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
6.5field-weighted citation impact, top 3% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
42 citing papers in PubMed, 72 citations in OpenAlex.
- Prediabetic cardiomyopathy is attenuated by hypothalamic PVN oxytocin neuron activation.The Journal of physiology · 2026Article
- Metabolic dysfunction-associated steatotic liver disease is associated with myocardial ischemia in patients with suspected or known coronary artery disease, especially in patients without obstructive coronary artery disease.BMC medical imaging · 2026Article
- The Clinical Role and Impact of Dobutamine Stress Echocardiography in Liver Transplantation.Echocardiography (Mount Kisco, N.Y.) · 2026Article
- Organ cross-talk: molecular mechanisms, biological functions, and therapeutic interventions for diseases.Signal transduction and targeted therapy · 2026Review
- Hypoxia-inducible factors in the immunometabolism of metabolic dysfunction-associated steatotic liver disease (MASLD): molecular mechanisms and therapeutic implications.Frontiers in physiology · 2026Article
- Effect of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) on Left Ventricular Mechanics in Patients Without Overt Cardiac Disease: A Systematic Review and Meta-Analysis.Journal of clinical medicine · 2025Review
- Skeletal muscle adiposity, coronary microvascular dysfunction, and adverse cardiovascular outcomes.European heart journal · 2025Article
- Evolution of Coronary Microvascular Dysfunction Prevalence over Time and Across Diagnostic Modalities in Patients with ANOCA: A Systematic Review.Journal of clinical medicine · 2025Review
- Coronary microvascular dysfunction: a review of its association with extracardiac organ pathologies.Frontiers in cardiovascular medicine · 2025Review
- Article
- The differences between patients with nonalcoholic fatty liver disease (NAFLD) and those without NAFLD, as well as predictors of functional coronary artery ischemia in patients with NAFLD.Clinical cardiology · 2024Article
- Body Composition, Coronary Microvascular Dysfunction, and Future Risk of Cardiovascular Events Including Heart Failure.JACC. Cardiovascular imaging · 2024Article
- Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and MACCEs in Patients with Diabetic Foot Ulcers: An Ambispective Longitudinal Cohort Study.Diabetes, metabolic syndrome and obesity : targets and therapy · 2024Article
- Association between non-alcoholic fatty liver disease and subclinical left ventricular dysfunction in the general population.European heart journal open · 2023Article
- Impacts of Non-alcoholic Fatty Liver Disease on Acute Coronary Syndrome: Evidence and Controversies.Current atherosclerosis reports · 2023Review
- Nonalcoholic fatty liver disease is associated with myocardial ischemia by CT myocardial perfusion imaging, independent of clinical and coronary CT angiography characteristics.European radiology · 2023Article
- Short-term PET-derived kinetic estimation for the diagnosis of hepatocellular carcinoma: a combination of the maximum-slope method and dual-input three-compartment model.Insights into imaging · 2023Article
- Decreased liver-to-spleen ratio in low-dose computed tomography as a biomarker of fatty liver disease reflects risk for myocardial ischaemia.European heart journal. Imaging methods and practice · 2023Article
- Heart failure with preserved ejection fraction and non-alcoholic fatty liver disease: new insights from bioinformatics.ESC heart failure · 2023Article
- The Network between Heart and Liver from the View of Persian Medicine Versus Conventional Medicine.Galen medical journal · 2023Article
Corrections and comments
- Commented on by
Authors and funding
17 authors at 1 institution in 3 countries.
Tomas VitaFrom the Cardiovascular Imaging Program, Departments of Medicine (Cardiovascular Division) and Radiology (T.V., D.J.M., M.T.O., N.S.B., A.K., A.J.D.M., P.B., J.H., C.F.B., M.L.S., V.R.T., H.S., R.B., M.F.D.C., S.D.), Division of Nuclear Medicine and Molecular Imaging, Department of Radiology (S.J., A.N., J.H., C.F.B., V.R.T., M.F.D.C., S.D.), and Cardiovascular Division (V.R.T., H.S., R.B., M.F.D.C., S.D.), Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115; Department of Radiology, St Vincent's University Hospital, Dublin, Ireland (D.J.M.); Cardiac MR/PET/CT Program, Departments of Medicine and Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Mass (M.T.O.); and Division of Cardiology, Department of Internal Medicine and Radiology, University of Alabama at Birmingham, Birmingham, Ala (N.S.B.).
David J MurphyFrom the Cardiovascular Imaging Program, Departments of Medicine (Cardiovascular Division) and Radiology (T.V., D.J.M., M.T.O., N.S.B., A.K., A.J.D.M., P.B., J.H., C.F.B., M.L.S., V.R.T., H.S., R.B., M.F.D.C., S.D.), Division of Nuclear Medicine and Molecular Imaging, Department of Radiology (S.J., A.N., J.H., C.F.B., V.R.T., M.F.D.C., S.D.), and Cardiovascular Division (V.R.T., H.S., R.B., M.F.D.C., S.D.), Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115; Department of Radiology, St Vincent's University Hospital, Dublin, Ireland (D.J.M.); Cardiac MR/PET/CT Program, Departments of Medicine and Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Mass (M.T.O.); and Division of Cardiology, Department of Internal Medicine and Radiology, University of Alabama at Birmingham, Birmingham, Ala (N.S.B.).ORCID 0000-0002-0361-672X
Michael T OsborneFrom the Cardiovascular Imaging Program, Departments of Medicine (Cardiovascular Division) and Radiology (T.V., D.J.M., M.T.O., N.S.B., A.K., A.J.D.M., P.B., J.H., C.F.B., M.L.S., V.R.T., H.S., R.B., M.F.D.C., S.D.), Division of Nuclear Medicine and Molecular Imaging, Department of Radiology (S.J., A.N., J.H., C.F.B., V.R.T., M.F.D.C., S.D.), and Cardiovascular Division (V.R.T., H.S., R.B., M.F.D.C., S.D.), Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115; Department of Radiology, St Vincent's University Hospital, Dublin, Ireland (D.J.M.); Cardiac MR/PET/CT Program, Departments of Medicine and Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Mass (M.T.O.); and Division of Cardiology, Department of Internal Medicine and Radiology, University of Alabama at Birmingham, Birmingham, Ala (N.S.B.).ORCID 0000-0003-1001-1718
Navkaranbir S BajajFrom the Cardiovascular Imaging Program, Departments of Medicine (Cardiovascular Division) and Radiology (T.V., D.J.M., M.T.O., N.S.B., A.K., A.J.D.M., P.B., J.H., C.F.B., M.L.S., V.R.T., H.S., R.B., M.F.D.C., S.D.), Division of Nuclear Medicine and Molecular Imaging, Department of Radiology (S.J., A.N., J.H., C.F.B., V.R.T., M.F.D.C., S.D.), and Cardiovascular Division (V.R.T., H.S., R.B., M.F.D.C., S.D.), Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115; Department of Radiology, St Vincent's University Hospital, Dublin, Ireland (D.J.M.); Cardiac MR/PET/CT Program, Departments of Medicine and Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Mass (M.T.O.); and Division of Cardiology, Department of Internal Medicine and Radiology, University of Alabama at Birmingham, Birmingham, Ala (N.S.B.).ORCID 0000-0002-4605-0797
Abhishek KeraliyaFrom the Cardiovascular Imaging Program, Departments of Medicine (Cardiovascular Division) and Radiology (T.V., D.J.M., M.T.O., N.S.B., A.K., A.J.D.M., P.B., J.H., C.F.B., M.L.S., V.R.T., H.S., R.B., M.F.D.C., S.D.), Division of Nuclear Medicine and Molecular Imaging, Department of Radiology (S.J., A.N., J.H., C.F.B., V.R.T., M.F.D.C., S.D.), and Cardiovascular Division (V.R.T., H.S., R.B., M.F.D.C., S.D.), Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115; Department of Radiology, St Vincent's University Hospital, Dublin, Ireland (D.J.M.); Cardiac MR/PET/CT Program, Departments of Medicine and Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Mass (M.T.O.); and Division of Cardiology, Department of Internal Medicine and Radiology, University of Alabama at Birmingham, Birmingham, Ala (N.S.B.).ORCID 0000-0001-7850-8144
Sophia JacobFrom the Cardiovascular Imaging Program, Departments of Medicine (Cardiovascular Division) and Radiology (T.V., D.J.M., M.T.O., N.S.B., A.K., A.J.D.M., P.B., J.H., C.F.B., M.L.S., V.R.T., H.S., R.B., M.F.D.C., S.D.), Division of Nuclear Medicine and Molecular Imaging, Department of Radiology (S.J., A.N., J.H., C.F.B., V.R.T., M.F.D.C., S.D.), and Cardiovascular Division (V.R.T., H.S., R.B., M.F.D.C., S.D.), Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115; Department of Radiology, St Vincent's University Hospital, Dublin, Ireland (D.J.M.); Cardiac MR/PET/CT Program, Departments of Medicine and Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Mass (M.T.O.); and Division of Cardiology, Department of Internal Medicine and Radiology, University of Alabama at Birmingham, Birmingham, Ala (N.S.B.).ORCID 0000-0001-6733-0184
Angel Joel Diaz MartinezFrom the Cardiovascular Imaging Program, Departments of Medicine (Cardiovascular Division) and Radiology (T.V., D.J.M., M.T.O., N.S.B., A.K., A.J.D.M., P.B., J.H., C.F.B., M.L.S., V.R.T., H.S., R.B., M.F.D.C., S.D.), Division of Nuclear Medicine and Molecular Imaging, Department of Radiology (S.J., A.N., J.H., C.F.B., V.R.T., M.F.D.C., S.D.), and Cardiovascular Division (V.R.T., H.S., R.B., M.F.D.C., S.D.), Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115; Department of Radiology, St Vincent's University Hospital, Dublin, Ireland (D.J.M.); Cardiac MR/PET/CT Program, Departments of Medicine and Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Mass (M.T.O.); and Division of Cardiology, Department of Internal Medicine and Radiology, University of Alabama at Birmingham, Birmingham, Ala (N.S.B.).
Ariana NodoushaniFrom the Cardiovascular Imaging Program, Departments of Medicine (Cardiovascular Division) and Radiology (T.V., D.J.M., M.T.O., N.S.B., A.K., A.J.D.M., P.B., J.H., C.F.B., M.L.S., V.R.T., H.S., R.B., M.F.D.C., S.D.), Division of Nuclear Medicine and Molecular Imaging, Department of Radiology (S.J., A.N., J.H., C.F.B., V.R.T., M.F.D.C., S.D.), and Cardiovascular Division (V.R.T., H.S., R.B., M.F.D.C., S.D.), Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115; Department of Radiology, St Vincent's University Hospital, Dublin, Ireland (D.J.M.); Cardiac MR/PET/CT Program, Departments of Medicine and Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Mass (M.T.O.); and Division of Cardiology, Department of Internal Medicine and Radiology, University of Alabama at Birmingham, Birmingham, Ala (N.S.B.).
Paco BravoFrom the Cardiovascular Imaging Program, Departments of Medicine (Cardiovascular Division) and Radiology (T.V., D.J.M., M.T.O., N.S.B., A.K., A.J.D.M., P.B., J.H., C.F.B., M.L.S., V.R.T., H.S., R.B., M.F.D.C., S.D.), Division of Nuclear Medicine and Molecular Imaging, Department of Radiology (S.J., A.N., J.H., C.F.B., V.R.T., M.F.D.C., S.D.), and Cardiovascular Division (V.R.T., H.S., R.B., M.F.D.C., S.D.), Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115; Department of Radiology, St Vincent's University Hospital, Dublin, Ireland (D.J.M.); Cardiac MR/PET/CT Program, Departments of Medicine and Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Mass (M.T.O.); and Division of Cardiology, Department of Internal Medicine and Radiology, University of Alabama at Birmingham, Birmingham, Ala (N.S.B.).ORCID 0000-0002-0022-4376
Jon HainerFrom the Cardiovascular Imaging Program, Departments of Medicine (Cardiovascular Division) and Radiology (T.V., D.J.M., M.T.O., N.S.B., A.K., A.J.D.M., P.B., J.H., C.F.B., M.L.S., V.R.T., H.S., R.B., M.F.D.C., S.D.), Division of Nuclear Medicine and Molecular Imaging, Department of Radiology (S.J., A.N., J.H., C.F.B., V.R.T., M.F.D.C., S.D.), and Cardiovascular Division (V.R.T., H.S., R.B., M.F.D.C., S.D.), Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115; Department of Radiology, St Vincent's University Hospital, Dublin, Ireland (D.J.M.); Cardiac MR/PET/CT Program, Departments of Medicine and Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Mass (M.T.O.); and Division of Cardiology, Department of Internal Medicine and Radiology, University of Alabama at Birmingham, Birmingham, Ala (N.S.B.).ORCID 0000-0002-0572-912X
Courtney F BibboFrom the Cardiovascular Imaging Program, Departments of Medicine (Cardiovascular Division) and Radiology (T.V., D.J.M., M.T.O., N.S.B., A.K., A.J.D.M., P.B., J.H., C.F.B., M.L.S., V.R.T., H.S., R.B., M.F.D.C., S.D.), Division of Nuclear Medicine and Molecular Imaging, Department of Radiology (S.J., A.N., J.H., C.F.B., V.R.T., M.F.D.C., S.D.), and Cardiovascular Division (V.R.T., H.S., R.B., M.F.D.C., S.D.), Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115; Department of Radiology, St Vincent's University Hospital, Dublin, Ireland (D.J.M.); Cardiac MR/PET/CT Program, Departments of Medicine and Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Mass (M.T.O.); and Division of Cardiology, Department of Internal Medicine and Radiology, University of Alabama at Birmingham, Birmingham, Ala (N.S.B.).ORCID 0000-0003-2937-0622
Michael L SteignerFrom the Cardiovascular Imaging Program, Departments of Medicine (Cardiovascular Division) and Radiology (T.V., D.J.M., M.T.O., N.S.B., A.K., A.J.D.M., P.B., J.H., C.F.B., M.L.S., V.R.T., H.S., R.B., M.F.D.C., S.D.), Division of Nuclear Medicine and Molecular Imaging, Department of Radiology (S.J., A.N., J.H., C.F.B., V.R.T., M.F.D.C., S.D.), and Cardiovascular Division (V.R.T., H.S., R.B., M.F.D.C., S.D.), Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115; Department of Radiology, St Vincent's University Hospital, Dublin, Ireland (D.J.M.); Cardiac MR/PET/CT Program, Departments of Medicine and Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Mass (M.T.O.); and Division of Cardiology, Department of Internal Medicine and Radiology, University of Alabama at Birmingham, Birmingham, Ala (N.S.B.).ORCID 0000-0002-3742-4267
Viviany R TaquetiFrom the Cardiovascular Imaging Program, Departments of Medicine (Cardiovascular Division) and Radiology (T.V., D.J.M., M.T.O., N.S.B., A.K., A.J.D.M., P.B., J.H., C.F.B., M.L.S., V.R.T., H.S., R.B., M.F.D.C., S.D.), Division of Nuclear Medicine and Molecular Imaging, Department of Radiology (S.J., A.N., J.H., C.F.B., V.R.T., M.F.D.C., S.D.), and Cardiovascular Division (V.R.T., H.S., R.B., M.F.D.C., S.D.), Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115; Department of Radiology, St Vincent's University Hospital, Dublin, Ireland (D.J.M.); Cardiac MR/PET/CT Program, Departments of Medicine and Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Mass (M.T.O.); and Division of Cardiology, Department of Internal Medicine and Radiology, University of Alabama at Birmingham, Birmingham, Ala (N.S.B.).ORCID 0000-0002-0136-3781
Hicham SkaliFrom the Cardiovascular Imaging Program, Departments of Medicine (Cardiovascular Division) and Radiology (T.V., D.J.M., M.T.O., N.S.B., A.K., A.J.D.M., P.B., J.H., C.F.B., M.L.S., V.R.T., H.S., R.B., M.F.D.C., S.D.), Division of Nuclear Medicine and Molecular Imaging, Department of Radiology (S.J., A.N., J.H., C.F.B., V.R.T., M.F.D.C., S.D.), and Cardiovascular Division (V.R.T., H.S., R.B., M.F.D.C., S.D.), Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115; Department of Radiology, St Vincent's University Hospital, Dublin, Ireland (D.J.M.); Cardiac MR/PET/CT Program, Departments of Medicine and Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Mass (M.T.O.); and Division of Cardiology, Department of Internal Medicine and Radiology, University of Alabama at Birmingham, Birmingham, Ala (N.S.B.).ORCID 0000-0002-5629-4138
Ron BlanksteinFrom the Cardiovascular Imaging Program, Departments of Medicine (Cardiovascular Division) and Radiology (T.V., D.J.M., M.T.O., N.S.B., A.K., A.J.D.M., P.B., J.H., C.F.B., M.L.S., V.R.T., H.S., R.B., M.F.D.C., S.D.), Division of Nuclear Medicine and Molecular Imaging, Department of Radiology (S.J., A.N., J.H., C.F.B., V.R.T., M.F.D.C., S.D.), and Cardiovascular Division (V.R.T., H.S., R.B., M.F.D.C., S.D.), Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115; Department of Radiology, St Vincent's University Hospital, Dublin, Ireland (D.J.M.); Cardiac MR/PET/CT Program, Departments of Medicine and Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Mass (M.T.O.); and Division of Cardiology, Department of Internal Medicine and Radiology, University of Alabama at Birmingham, Birmingham, Ala (N.S.B.).
Marcelo F Di CarliFrom the Cardiovascular Imaging Program, Departments of Medicine (Cardiovascular Division) and Radiology (T.V., D.J.M., M.T.O., N.S.B., A.K., A.J.D.M., P.B., J.H., C.F.B., M.L.S., V.R.T., H.S., R.B., M.F.D.C., S.D.), Division of Nuclear Medicine and Molecular Imaging, Department of Radiology (S.J., A.N., J.H., C.F.B., V.R.T., M.F.D.C., S.D.), and Cardiovascular Division (V.R.T., H.S., R.B., M.F.D.C., S.D.), Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115; Department of Radiology, St Vincent's University Hospital, Dublin, Ireland (D.J.M.); Cardiac MR/PET/CT Program, Departments of Medicine and Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Mass (M.T.O.); and Division of Cardiology, Department of Internal Medicine and Radiology, University of Alabama at Birmingham, Birmingham, Ala (N.S.B.).
Sharmila DorbalaFrom the Cardiovascular Imaging Program, Departments of Medicine (Cardiovascular Division) and Radiology (T.V., D.J.M., M.T.O., N.S.B., A.K., A.J.D.M., P.B., J.H., C.F.B., M.L.S., V.R.T., H.S., R.B., M.F.D.C., S.D.), Division of Nuclear Medicine and Molecular Imaging, Department of Radiology (S.J., A.N., J.H., C.F.B., V.R.T., M.F.D.C., S.D.), and Cardiovascular Division (V.R.T., H.S., R.B., M.F.D.C., S.D.), Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115; Department of Radiology, St Vincent's University Hospital, Dublin, Ireland (D.J.M.); Cardiac MR/PET/CT Program, Departments of Medicine and Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Mass (M.T.O.); and Division of Cardiology, Department of Internal Medicine and Radiology, University of Alabama at Birmingham, Birmingham, Ala (N.S.B.).ORCID 0000-0003-1462-1185
Brigham and Women's Hospital · US
Funding
Institutional Career Development CoreKL2TR002542 · NCATS · HARVARD MEDICAL SCHOOL · PI BREDELLA, MIRIAM ANTOINETTE, RUTKOVE, SEWARD B. · 2018 to 2022
$8.7MNoninvasive Cardiovascular Imaging Research Training ProgramT32HL094301 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI Marcelo F DI CARLI · 2010 to 2026
$7.8MCardiac MR and CT ResearchT32HL076136 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI NEILAN, TOMAS G · 2004 to 2019
$4.9MExtension to Coronary Flow Reserve to Assess Hidden Risk: Focus on Women, Heart Failure, and InflammationK23HL135438 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI TAQUETI, VIVIANY R · 2017 to 2021
$1.1MNCATS NIH HHS KL2 TR002542NHLBI NIH HHS K23 HL135438NHLBI NIH HHS T32 HL076136NHLBI NIH HHS T32 HL094301
Abstract
Background Cardiovascular disease is a major cause of mortality in patients with nonalcoholic fatty liver disease (NAFLD). However, the association of NAFLD with coronary microvascular dysfunction is, to our knowledge, unknown. Purpose To determine whether coronary microvascular dysfunction is more prevalent in patients with NAFLD and to determine whether coronary microvascular dysfunction predicts major adverse cardiac events (MACE) independently of NAFLD. Materials and Methods This retrospective study (2006-2014) included patients without evidence of obstructive epicardial coronary artery disease and healthy left ventricular ejection fraction (≥40%) at a clinical rest and stress myocardial perfusion PET/CT. NAFLD was defined by a mean hepatic attenuation of less than 40 HU at CT and coronary microvascular dysfunction as a coronary flow reserve (CFR) of less than 2.0. A composite of all-cause mortality, myocardial infarction, coronary revascularization, and hospitalization because of heart failure comprised MACE (130 of 886 patients; 14.7%). The relation between NAFLD and MACE was assessed by using multivariable Cox regression analysis. Results Among 886 patients (mean age, 62 years ± 12 [standard deviation]; 631 women [mean age, 62 years ± 12 years] and 255 men [mean age, 61 years ± 12]; and ejection fraction, 63% ± 9), 125 patients (14.1%) had NAFLD and 411 patients (46.4%) had coronary microvascular dysfunction. Coronary microvascular dysfunction was more prevalent (64.8% vs 43.4%;
Indexed as
Coronary Artery DiseaseNon-alcoholic Fatty Liver DiseaseAgedFemaleHumansMaleMiddle AgedPositron Emission Tomography Computed TomographyRetrospective StudiesRisk Factors
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.